1
Clinical Trials associated with Shuangshen Xionglian Granules双参芎连颗粒治疗冠心病痰瘀互结证的IIa期临床研究
[Translation] Phase IIa clinical study of Shuangshen Xionglian granules in the treatment of phlegm and blood stasis syndrome in coronary heart disease
初步评价双参芎连颗粒治疗冠心病稳定型心绞痛(痰瘀互结证)的有效性和安全性,同时对其作用机制进行探索,为下一步临床试验提供依据。
[Translation] To preliminarily evaluate the effectiveness and safety of Shuangshen Xionglian Granules in the treatment of stable angina pectoris (phlegm and blood stasis syndrome) in coronary heart disease, and explore its mechanism of action to provide a basis for the next clinical trial.
100 Clinical Results associated with Shuangshen Xionglian Granules
100 Translational Medicine associated with Shuangshen Xionglian Granules
100 Patents (Medical) associated with Shuangshen Xionglian Granules
100 Deals associated with Shuangshen Xionglian Granules